Enzalutamide, Abiraterone Compared for mCRPC With Comorbidities
Patients with comorbidities are not routinely included in clinical trials.
All articles by Natasha Persaud
Metastasis-Directed Therapy Alone May Treat Solitary Prostate Cancer Recurrence
This is the first study to assess the role of metastasis-directed therapy in solitary metastatic oligorecurrent prostate cancer in the absence of systemic therapy.
Repeat TURBT Before RC Does Not Improve Bladder Cancer Outcomes
Study results suggest that tumor debulking does not benefit patients undergoing radical cystectomy.
Proteinuria, AKI With New Tyrosine Kinase Inhibitors Characterized
Proteinuria was more frequent with regorafenib than with axitinib.
Cediranib Improves rPFS in Metastatic Castration-Resistant Prostate Cancer
Adding cediranib to olaparib more than doubled the median radiographic progression-free survival.
Transperineal Prostate Biopsy Without Antibiotic Prophylaxis Appears Safe
Researchers conducted the first randomized clinical trial evaluating whether prophylactic antibiotics are needed for transperineal prostate biopsy.
Local Docetaxel Therapy May Benefit Patients With High-Risk NMIBC
Of 19 patients with high-risk NMIBC treated with local docetaxel, 14 had prior BCG exposure.
T1a RCC Death Risk Higher After Ablation vs Partial Nephrectomy
The study included a large, contemporary cohort of patients with T1a renal cell carcinoma undergoing partial nephrectomy or local tumor destruction.
Upstaging After PSMA PET for High-Risk Prostate Cancer Increasing
Study findings suggest that PSMA PET results may alter treatment decisions in high-risk prostate cancer.
Active Surveillance Best Suited for Older Men With Low-Risk Prostate Cancer
Researchers assessed 30-year trajectories of prostate cancer in men with very low- to intermediate-risk prostate cancer on active surveillance.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...